Chapman R - Search Results

1

Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children.

Wasserman M, Chapman R, Lapidot R, Sutton K, Dillon-Murphy D, Patel S, Chilson E, Snow V, Farkouh R, Pelton S. Wasserman M, et al. Among authors: chapman r. Emerg Infect Dis. 2021;27(6):1627-1636. doi: 10.3201/eid2706.204238. Emerg Infect Dis. 2021. PMID: 34013855 Free PMC article. Review.

2

Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis.

Chapman R, Sutton K, Dillon-Murphy D, Patel S, Hilton B, Farkouh R, Wasserman M. Chapman R, et al. Vaccine. 2020 Oct 21;38(45):7138-7145. doi: 10.1016/j.vaccine.2020.08.068. Epub 2020 Sep 8. Vaccine. 2020. PMID: 32912642 Free article.

3

Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges.

Horn EK, Wasserman MD, Hall-Murray C, Sings HL, Chapman R, Farkouh RA. Horn EK, et al. Among authors: chapman r. Expert Rev Vaccines. 2021 Oct;20(10):1291-1309. doi: 10.1080/14760584.2021.1971521. Epub 2021 Sep 11. Expert Rev Vaccines. 2021. PMID: 34424123 Review.

4

Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants.

Rozenbaum MH, Huang L, Perdrizet J, Cane A, Arguedas A, Hayford K, Tort MJ, Chapman R, Dillon-Murphy D, Snow V, Chilson E, Farkouh RA. Rozenbaum MH, et al. Among authors: chapman r. Vaccine. 2024 Jan 25;42(3):573-582. doi: 10.1016/j.vaccine.2023.12.057. Epub 2024 Jan 7. Vaccine. 2024. PMID: 38191278 Free article.

5

Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13.

Rozenbaum MH, Huang L, Cane A, Arguedas A, Chapman R, Dillon-Murphy D, Tort MJ, Snow V, Chilson E, Farkouh R. Rozenbaum MH, et al. Among authors: chapman r. J Med Econ. 2024 Jan-Dec;27(1):644-652. doi: 10.1080/13696998.2024.2339638. Epub 2024 Apr 19. J Med Econ. 2024. PMID: 38577742 Free article.

6

Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population.

Lytle D, Grajales Beltrán AG, Perdrizet J, Ait Yahia N, Cane A, Yarnoff B, Chapman R. Lytle D, et al. Among authors: chapman r. Hum Vaccin Immunother. 2023 Aug;19(2):2257426. doi: 10.1080/21645515.2023.2257426. Epub 2023 Sep 29. Hum Vaccin Immunother. 2023. PMID: 37771288 Free PMC article.

7

Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021.

Mendes D, Chapman R, Gal P, Atwell J, Nguyen JL, Hamson L, Di Fusco M, Czudek C, Yang J. Mendes D, et al. Among authors: chapman r. J Med Econ. 2022 Jan-Dec;25(1):1039-1050. doi: 10.1080/13696998.2022.2111935. J Med Econ. 2022. PMID: 36097853 Free article.

8

Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance.

Mendes D, Chapman R, Aruffo E, Gal P, Nguyen JL, Hamson L, Di Fusco M, Czudek C, Yang J. Mendes D, et al. Among authors: chapman r. Expert Rev Vaccines. 2023 Jan-Dec;22(1):90-103. doi: 10.1080/14760584.2023.2158816. Epub 2023 Jan 3. Expert Rev Vaccines. 2023. PMID: 36519401 Free article.

9

Outcome Scores and Survivorship of Patients Undergoing Primary Hip Arthroscopy With Borderline Hip Dysplasia: A Propensity-Matched Study With Minimum 10-Year Follow-up.

Chapman RS, Allahabadi S, Fenn TW, Larson JH, Beals CT, Kaplan DJ, Nho SJ. Chapman RS, et al. Am J Sports Med. 2024 May 14:3635465241247287. doi: 10.1177/03635465241247287. Online ahead of print. Am J Sports Med. 2024. PMID: 38742441

10

Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol.

Zeissler ML, Bakshi N, Bartlett M, Batla A, Byrom D, Chapman R, Collins S, Cowd E, Deeson E, Ellis-Doyle R, Forbes J, Gonzalez-Robles C, Jewell A, Lane EL, LaPelle NR, Martin K, Matthews H, Miller L, Mills G, Morgan A, Parry M, Pushparatnam K, Ratcliffe N, Salathiel D, Scurfield P, Siu C, Whipps S, Wonnacott S, Foltynie T, Carroll CB, McFarthing K; EJS ACT-PD consortium. Zeissler ML, et al. Among authors: chapman r. J Parkinsons Dis. 2024 Apr 27. doi: 10.3233/JPD-230444. Online ahead of print. J Parkinsons Dis. 2024. PMID: 38701161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,075 results

Search Page